Sub menu

 
 

Therapeutic Goods (Serious Scarcity and Substitutable Medicine) (Gliclazide) Instrument 2024

This legislation addresses serious scarcity of gliclazide, allowing substitution of alternative medicines to ensure continued treatment for patients with diabetes.

Official version of legislation

The Federal Register of Legislation is the authorised Australian Government website for Commonwealth legislation. It contains the full text and details of the life cycle of individual laws.

Read the legislation

Help us improve the Therapeutic Goods Administration site